Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

NCT05702450 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Keymed Biosciences Co.Ltd